Ciboz 400 (Rifaximin Tablet) 400mg

Ciboz 400 is a rifaximin-based antibiotic tablet used to address gastrointestinal issues like traveler's diarrhea and IBS symptoms. This 400mg formulation offers a convenient 100-tablet pack for broad-spectrum antibacterial support. Ideal for short-term use under medical guidance.

Strength

400mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

LUPIN LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ciboz 400 is commonly used to treat traveler's diarrhea caused by noninvasive strains of E. coli. It also helps manage symptoms of irritable bowel syndrome with diarrhea (IBS-D) in adults. This antibiotic works within the gut to reduce harmful bacteria without significant systemic absorption.

Side Effects

Users often report reduced abdominal discomfort and fewer loose stools within a few days of starting Ciboz 400. The tablet form allows for easy swallowing and consistent dosing. Some may experience mild digestive changes as the gut microbiome adjusts.

Precautions & Warnings

Store Ciboz 400 at room temperature away from moisture and direct light. Keep out of reach of children and pets. If you have a fever or bloody diarrhea, consult a healthcare provider before use. Complete the full prescribed course unless directed otherwise.

Avoid Interactions

Ciboz 400 may interact with certain anticoagulants or immunosuppressants; consult a doctor if you take these medications. Avoid alcohol during treatment as it may worsen digestive side effects. CYP3A4 inhibitors could potentially alter rifaximin levels in the body.

References

Frequently Asked Questions

Ciboz 400 is primarily used to treat traveler's diarrhea and manage symptoms of IBS-D in adults.

Some users notice improvement within a few days, but full effects depend on individual response and adherence to the prescribed course.

Availability varies by region; consult local regulations and a healthcare provider before purchasing.

Avoid alcohol and consult your doctor about other medications to prevent potential interactions.

This medication is typically prescribed for short-term use; long-term safety should be discussed with a healthcare professional.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.